AI Networking Cookbook: Practical recipes for AI-assisted network automation and development
We have 2 of 45 papers
We haven’t gathered this author’s papers yet. Follow them and we’ll fetch their work.
Not the right person? Other researchers publish under this name.
T-DM1 demonstrated heterogenous efficacy among HER2-amplified tumor types, with promising response and outcomes among patients with salivary gland cancer.
Pemetrexed single agent or in combination with carboplatin has comparable efficacy to approved second-line therapies for advanced thyroid cancer and prospective Phase II and III clinical trials are needed to confirm the efficacy of this salvage therapy.
We use cookies to run the site and, with your consent, for analytics and to show ads. See our Cookie Policy.